Orfadin - NDC Database


8 records found:

Sorted by NDC Code

Page of 1
66621-1002 Jan 18, 2002
Orfadin 2 mg Oral Capsule by Rare Disease Therapeutics, Inc.
66621-1005 Jan 18, 2002
Orfadin (Nitisinone 5 mg) by Rare Disease Therapeutics, Inc.
66621-1010 Jan 18, 2002
Orfadin 10 mg Oral Capsule by Rare Disease Therapeutics, Inc.
66658-102 Jul 01, 2016
Orfadin 2 mg Oral Capsule by Swedish Orphan Biovitrum Ab (Publ)
66658-105 Jul 01, 2016
Orfadin 5 mg Oral Capsule by Swedish Orphan Biovitrum Ab (Publ)
66658-110 Jul 01, 2016
Orfadin 10 mg Oral Capsule by Swedish Orphan Biovitrum Ab (Publ)
66658-120 Jul 01, 2016
Orfadin 20 mg Oral Capsule by Swedish Orphan Biovitrum Ab (Publ)
66658-204 Jun 01, 2016
Orfadin 4 mg/ml Oral Suspension by Swedish Orphan Biovitrum Ab (Publ)

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 April 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA